Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review

被引：0
|
作者：
Reyhaneh Manafi-Farid
Sara Harsini
Bahare Saidi
Hojat Ahmadzadehfar
Ken Herrmann
Alberto Briganti
Jochen Walz
Mohsen Beheshti
机构：
[1] Tehran University of Medical sciences,Research Center for Nuclear Medicine
[2] Universal Scientific Education and Research Network (USERN),Association of Nuclear Medicine and Molecular Imaging (ANMMI)
[3] Klinikum Westfalen,Department of Nuclear Medicine
[4] University Hospital,Department of Nuclear Medicine
[5] Vita-Salute San Raffaele University,Urological Research Institute, Scientific Institute San Raffaele
[6] Institute Paoli-Calmettes Cancer Centre,Department of Urology
[7] Department of Nuclear Medicine & Endocrinology,Division of Molecular Imaging and Theranostics
[8] Paracelsus Medical University,Department of Nuclear Medicine
[9] University Hospital,undefined
[10] RWTH University,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
[; Lu]Lu-PSMA; Radioligand therapy; Predictive factors; Response to therapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4028 / 4041
页数：13
相关论文
共 50 条
  • [1] Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
    Manafi-Farid, Reyhaneh
    Harsini, Sara
    Saidi, Bahare
    Ahmadzadehfar, Hojat
    Herrmann, Ken
    Briganti, Alberto
    Walz, Jochen
    Beheshti, Mohsen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (12) : 4028 - 4041
  • [2] Factors predicting the early biochemical response to [177Lu]Lu-PSMA therapy in patients with metastatic castration resistant prostate cancer
    Al-Timimi, Ahmed
    Manafi-Farid, Reyhaneh
    Fallahi, Babak
    Beiki, Davood
    Askari, Emran
    Rezaei, Alireza
    Adinehpour, Zohreh
    Eftekhari, Mohammad
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2022, 30 (02): : 115 - 121
  • [3] Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617
    Ferdinandus, Justin
    Eppard, Elisabeth
    Gaertner, Florian C.
    Kuerpig, Stefan
    Fimmers, Rolf
    Yordanova, Anna
    Hauser, Stefan
    Feldmann, Georg
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 312 - 319
  • [4] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
    Wojciech Cytawa
    Robin Hendel
    Bartłomiej Tomasik
    Franz-Xaver Weinzierl
    Thorsten Bley
    Jacek Jassem
    Andreas Schirbel
    Andreas K. Buck
    Ralph A. Bundschuh
    Philipp E. Hartrampf
    Rudolf A. Werner
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3765 - 3776
  • [5] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
    Cytawa, Wojciech
    Hendel, Robin
    Tomasik, Bartlomiej
    Weinzierl, Franz-Xaver
    Bley, Thorsten
    Jassem, Jacek
    Schirbel, Andreas
    Buck, Andreas K.
    Bundschuh, Ralph A.
    Hartrampf, Philipp E.
    Werner, Rudolf A.
    Lapa, Constantin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3765 - 3776
  • [6] The value of tumor markers in men with metastatic prostate cancer undergoing [177Lu]Lu-PSMA therapy
    Yordanova, Anna
    Linden, Paula
    Hauser, Stefan
    Feldmann, Georg
    Brossart, Peter
    Fimmers, Rolf
    Essler, Markus
    Holdenrieder, Stefan
    Ahmadzadehfar, Hojjat
    PROSTATE, 2020, 80 (01): : 17 - 27
  • [7] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [8] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [9] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Buck, Andreas K.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Schirbel, Andreas
    Essler, Markus
    Bundschuh, Ralph A.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3269 - 3276
  • [10] Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy
    Ahmadzadehfar, Hojjat
    Schlolaut, Stephan
    Fimmers, Rolf
    Yordanova, Anna
    Hirzebruch, Stefan
    Schlenkhoff, Carl
    Gaertner, Florian C.
    Awang, Zool Hilmi
    Hauser, Stefan
    Essler, Markus
    ONCOTARGET, 2017, 8 (61) : 103108 - 103116
12345